US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
US3959457A
(en)
*
|
1970-06-05 |
1976-05-25 |
Temple University |
Microparticulate material and method of making such material
|
USRE29835E
(en)
|
1971-06-01 |
1978-11-14 |
Icn Pharmaceuticals |
1,2,4-Triazole nucleosides
|
US3798209A
(en)
*
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
US4526988A
(en)
*
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
NL8403224A
(nl)
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
IL85778A0
(en)
|
1987-03-20 |
1988-09-30 |
Bristol Myers Co |
Production of 2',3'-dideoxynucleosides and certain such novel compounds
|
GB8719367D0
(en)
|
1987-08-15 |
1987-09-23 |
Wellcome Found |
Therapeutic compounds
|
JPH03501253A
(ja)
|
1987-09-22 |
1991-03-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
エイズ(aids)治療を目的とするリポソームによるヌクレオシド類似物質
|
SE8802687D0
(sv)
|
1988-07-20 |
1988-07-20 |
Astra Ab |
Nucleoside derivatives
|
US5616702A
(en)
|
1988-11-15 |
1997-04-01 |
Merrell Pharmaceuticals Inc. |
2-'-ethenylidene cytidine, uridine and guanosine derivatives
|
US5705363A
(en)
*
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5411947A
(en)
*
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5194654A
(en)
*
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
DE3924424A1
(de)
|
1989-07-24 |
1991-01-31 |
Boehringer Mannheim Gmbh |
Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
US5026687A
(en)
*
|
1990-01-03 |
1991-06-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
|
DK0527815T3
(da)
*
|
1990-04-06 |
2000-11-06 |
Genelabs Tech Inc |
Hepatitis C-virus-epitop
|
AU7872491A
(en)
|
1990-05-07 |
1991-11-27 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
AU7623991A
(en)
|
1990-05-17 |
1991-11-21 |
Syntex (U.S.A.) Inc. |
Antiviral agents
|
WO1991018914A1
(en)
|
1990-05-29 |
1991-12-12 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
DK0533833T3
(da)
|
1990-06-13 |
1996-04-22 |
Arnold Glazier |
Phosphorprolægemidler
|
US5372808A
(en)
|
1990-10-17 |
1994-12-13 |
Amgen Inc. |
Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
|
US5543390A
(en)
*
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5543389A
(en)
*
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5595732A
(en)
*
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
US5157027A
(en)
|
1991-05-13 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Bisphosphonate squalene synthetase inhibitors and method
|
JPH07500573A
(ja)
|
1991-07-12 |
1995-01-19 |
ネクススター・ファーマシューティカルズ・インコーポレイテッド |
抗ウィルス性リポヌクレオシド:b型肝炎の治療
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
TW224053B
(xx)
|
1991-09-13 |
1994-05-21 |
Paul B Chretien |
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5405598A
(en)
*
|
1992-02-24 |
1995-04-11 |
Schinazi; Raymond F. |
Sensitizing agents for use in boron neutron capture therapy
|
US5610054A
(en)
*
|
1992-05-14 |
1997-03-11 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic RNA molecule targeted against Hepatitis C virus
|
US5256798A
(en)
|
1992-06-22 |
1993-10-26 |
Eli Lilly And Company |
Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
|
KR940000475A
(ko)
*
|
1992-06-22 |
1994-01-03 |
리로이 휘테커 |
알파-아노머가 풍부한 1-할로-2-데옥시-2, 2-디플루오로-d-리보푸라노실 유도체의 제조방법
|
US5426183A
(en)
*
|
1992-06-22 |
1995-06-20 |
Eli Lilly And Company |
Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
TW356472B
(en)
*
|
1992-09-01 |
1999-04-21 |
Lilly Co Eli |
A process for anomerizing nucleosides
|
GB9226729D0
(en)
|
1992-12-22 |
1993-02-17 |
Wellcome Found |
Therapeutic combination
|
AU6247594A
(en)
*
|
1993-02-24 |
1994-09-14 |
Jui H. Wang |
Compositions and methods of application of reactive antiviral polymers
|
CA2162574A1
(en)
|
1993-05-12 |
1994-11-24 |
Karl Y. Hostetler |
Acyclovir derivatives for topical use
|
TW374087B
(en)
|
1993-05-25 |
1999-11-11 |
Univ Yale |
L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
|
EP0773029A4
(en)
|
1993-07-19 |
1997-09-03 |
Tokyo Tanabe Co |
HEPATITIS C VIRUS PROLIFERATION INHIBITOR
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
US7375198B2
(en)
*
|
1993-10-26 |
2008-05-20 |
Affymetrix, Inc. |
Modified nucleic acid probes
|
DK0730470T3
(da)
*
|
1993-11-10 |
2002-06-03 |
Enzon Inc |
Forbedrede interferonpolymerkonjugater
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
WO1995024185A1
(en)
|
1994-03-11 |
1995-09-14 |
Isis Pharmaceuticals, Inc. |
Novel pyrimidine nucleosides
|
DE4415539C2
(de)
*
|
1994-05-03 |
1996-08-01 |
Osama Dr Dr Med Omer |
Pflanzen mit virustatischer und antiviraler Wirkung
|
EP0767657A4
(en)
*
|
1994-06-22 |
1999-01-20 |
Nexstar Pharmaceuticals Inc |
NEW METHOD FOR THE PRODUCTION OF KNOWN AND NEW 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILE SUBSTITUTION
|
DE4432623A1
(de)
*
|
1994-09-14 |
1996-03-21 |
Huels Chemische Werke Ag |
Verfahren zur Bleichung von wäßrigen Tensidlösungen
|
US5559101A
(en)
|
1994-10-24 |
1996-09-24 |
Genencor International, Inc. |
L-ribofuranosyl nucleosides
|
US5738846A
(en)
*
|
1994-11-10 |
1998-04-14 |
Enzon, Inc. |
Interferon polymer conjugates and process for preparing the same
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
US5703058A
(en)
*
|
1995-01-27 |
1997-12-30 |
Emory University |
Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
|
US6391859B1
(en)
*
|
1995-01-27 |
2002-05-21 |
Emory University |
[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
DE19514523A1
(de)
|
1995-04-12 |
1996-10-17 |
Schering Ag |
Neue Cytosin- und Cytidinderivate
|
US5908621A
(en)
*
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5767097A
(en)
*
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
GB9602028D0
(en)
*
|
1996-02-01 |
1996-04-03 |
Amersham Int Plc |
Nucleoside analogues
|
US5980884A
(en)
|
1996-02-05 |
1999-11-09 |
Amgen, Inc. |
Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
|
JP2000506010A
(ja)
*
|
1996-02-29 |
2000-05-23 |
イミューソル インコーポレイテッド |
C型肝炎ウイルスリボザイム
|
US5830905A
(en)
|
1996-03-29 |
1998-11-03 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5633388A
(en)
*
|
1996-03-29 |
1997-05-27 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
JP3235840B2
(ja)
|
1996-05-01 |
2001-12-04 |
イーライ・リリー・アンド・カンパニー |
プロテインキナーゼcのハロ置換阻害剤
|
US5990276A
(en)
|
1996-05-10 |
1999-11-23 |
Schering Corporation |
Synthetic inhibitors of hepatitis C virus NS3 protease
|
GB9609932D0
(en)
*
|
1996-05-13 |
1996-07-17 |
Hoffmann La Roche |
Use of IL-12 and IFN alpha for the treatment of infectious diseases
|
US5891874A
(en)
*
|
1996-06-05 |
1999-04-06 |
Eli Lilly And Company |
Anti-viral compound
|
US5837257A
(en)
|
1996-07-09 |
1998-11-17 |
Sage R&D |
Use of plant extracts for treatment of HIV, HCV and HBV infections
|
US5922757A
(en)
*
|
1996-09-30 |
1999-07-13 |
The Regents Of The University Of California |
Treatment and prevention of hepatic disorders
|
US6509320B1
(en)
*
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
CZ126799A3
(cs)
|
1996-10-16 |
1999-07-14 |
Icn Pharmaceuticals |
Purinové L-nukleosidy a jejich analogy a farmaceutické prostředky, které je obsahují
|
PL187107B1
(pl)
*
|
1996-10-16 |
2004-05-31 |
Icn Pharmaceuticals |
L-nukleozydy monocykliczne, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
|
US6455690B1
(en)
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
JP4080541B2
(ja)
|
1996-10-18 |
2008-04-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特にc型肝炎ウイルスns3プロテアーゼの阻害因子
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
IL119833A
(en)
*
|
1996-12-15 |
2001-01-11 |
Lavie David |
Hypericum perforatum extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
|
US20020127371A1
(en)
*
|
2001-03-06 |
2002-09-12 |
Weder Donald E. |
Decorative elements provided with a circular or crimped configuration at point of sale or point of use
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
CA2292558C
(en)
*
|
1997-06-30 |
2006-09-19 |
Merz + Co. Gmbh & Co. |
1-amino-alkylcyclohexane nmda receptor antagonists
|
TW434252B
(en)
|
1997-07-23 |
2001-05-16 |
Univ Georgia Res Found |
Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine
|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
ATE206618T1
(de)
|
1997-09-21 |
2001-10-15 |
Schering Corp |
Kombinationstherapie zur entfernung von nachweisbarer hcv-rns in patienten mit chronischer hepatitis c-infektion
|
US6703374B1
(en)
*
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US5981709A
(en)
|
1997-12-19 |
1999-11-09 |
Enzon, Inc. |
α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
|
ATE344271T1
(de)
|
1998-02-25 |
2006-11-15 |
Univ Emory |
2'-fluoronukleoside
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
JP5281726B2
(ja)
|
1998-05-15 |
2013-09-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
慢性C型肝炎感染を有する、抗ウイルス処置を受けていない患者における、リバビリンおよびインターフェロンαを含む併用療法
|
TR200003635T2
(tr)
|
1998-06-08 |
2001-04-20 |
F.Hoffmann-La Roche Ag |
Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması.
|
US6323180B1
(en)
*
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
WO2000009531A2
(en)
|
1998-08-10 |
2000-02-24 |
Novirio Pharmaceuticals Limited |
β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
|
FR2784892B1
(fr)
|
1998-10-23 |
2001-04-06 |
Smith & Nephew Kinetec Sa |
Attelle de mobilisation passive repliable pour membre inferieur
|
AU2157000A
(en)
|
1998-12-18 |
2000-07-12 |
Schering Corporation |
Ribavirin-pegylated interferon alfa induction hcv combination therapy
|
EP1225899A2
(en)
|
1999-11-04 |
2002-07-31 |
Virochem Pharma Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
MXPA02004779A
(es)
*
|
1999-11-12 |
2004-07-01 |
Pharmasset Ltd |
Sintesis de 2'-desoxi-l-nucleosidos.
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
CN1427722A
(zh)
|
2000-02-18 |
2003-07-02 |
希拉生物化学股份有限公司 |
用核苷类似物治疗或预防黄病毒感染的方法
|
ES2319732T3
(es)
|
2000-04-13 |
2009-05-12 |
Pharmasset, Inc. |
Derivados de nucleosido 3'- o 2'-hidroximetilo sustituido para el tratamiento de infecciones virales.
|
AU2001255495A1
(en)
|
2000-04-20 |
2001-11-07 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rnain patients having chronic hepatitis c infection
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EA005890B1
(ru)
|
2000-05-26 |
2005-06-30 |
Айденикс (Кайман) Лимитед |
СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
|
EA200601591A1
(ru)
*
|
2000-05-26 |
2007-02-27 |
Айденикс (Кайман) Лимитед |
Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
FR2810322B1
(fr)
*
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
MY141594A
(en)
|
2000-06-15 |
2010-05-14 |
Novirio Pharmaceuticals Ltd |
3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
*
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
CZ2003195A3
(cs)
|
2000-07-21 |
2003-04-16 |
Schering Corporation |
Peptidové inhibitory serinové proteázy NS3 a farmaceutický prostředek
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
WO2002008251A2
(en)
|
2000-07-21 |
2002-01-31 |
Corvas International, Inc. |
Peptides as ns3-serine protease inhibitors of hepatitis c virus
|
US6897201B2
(en)
*
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
US7018985B1
(en)
*
|
2000-08-21 |
2006-03-28 |
Inspire Pharmaceuticals, Inc. |
Composition and method for inhibiting platelet aggregation
|
AR039558A1
(es)
*
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
BR0114837A
(pt)
|
2000-10-18 |
2006-05-09 |
Pharmasset Ltd |
nucleosìdeos modificados para tratamento de infecções viróticas e proliferação celular anormal
|
HUP0301444A3
(en)
|
2000-10-18 |
2007-05-29 |
Schering Corp |
The use of ribavirin-pegylated interferon alfa for the preparation of pharmaceutical compositions for the treatment of hcv infection
|
US6555677B2
(en)
*
|
2000-10-31 |
2003-04-29 |
Merck & Co., Inc. |
Phase transfer catalyzed glycosidation of an indolocarbazole
|
HUP0500456A3
(en)
|
2000-11-20 |
2012-05-02 |
Bristol Myers Squibb Co |
Hepatitis c tripeptide inhibitors, pharmaceutical compositions comprising thereof and their use
|
DE20019797U1
(de)
|
2000-11-21 |
2001-04-05 |
Mala Verschlussysteme Gmbh |
Verschlußkappe
|
MXPA03005219A
(es)
|
2000-12-12 |
2003-09-25 |
Schering Corp |
Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c.
|
WO2002048116A2
(en)
|
2000-12-13 |
2002-06-20 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
US6727366B2
(en)
|
2000-12-13 |
2004-04-27 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
|
US6750396B2
(en)
|
2000-12-15 |
2004-06-15 |
Di/Dt, Inc. |
I-channel surface-mount connector
|
KR20030081343A
(ko)
|
2000-12-15 |
2003-10-17 |
파마셋, 리미티드 |
플라비비리다에 감염 치료용 항바이러스제
|
WO2002057287A2
(en)
|
2001-01-22 |
2002-07-25 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
US7105499B2
(en)
*
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US6962991B2
(en)
*
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
EP1432721A4
(en)
|
2001-09-13 |
2008-02-20 |
Bristol Myers Squibb Co |
PROCESS FOR THE PREPARATION OF REBECCAMYCIN AND ANALOGUE THEREOF
|
WO2003024461A1
(en)
|
2001-09-20 |
2003-03-27 |
Schering Corporation |
Hcv combination therapy
|
JP2005504087A
(ja)
*
|
2001-09-28 |
2005-02-10 |
イデニクス(ケイマン)リミテツド |
4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物
|
GB0129945D0
(en)
|
2001-12-13 |
2002-02-06 |
Mrc Technology Ltd |
Chemical compounds
|
AU2002365234B2
(en)
*
|
2001-12-14 |
2009-01-29 |
Pharmasset Inc |
N4-acylcytosine nucleosides for treatment of viral infections
|
AU2002353165A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
WO2003055896A2
(en)
*
|
2001-12-21 |
2003-07-10 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza l-nucleosides
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
CA2474563C
(en)
|
2002-02-13 |
2010-11-09 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
WO2003073989A2
(en)
*
|
2002-02-28 |
2003-09-12 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
CA2477741A1
(en)
*
|
2002-02-28 |
2003-09-04 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
AU2003241621A1
(en)
*
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
WO2003106477A1
(en)
|
2002-06-01 |
2003-12-24 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
|
JP2005533777A
(ja)
|
2002-06-17 |
2005-11-10 |
メルク エンド カムパニー インコーポレーテッド |
Rna抗ウイルス剤としての炭素環ヌクレオシドアナログ
|
EP1551421A2
(en)
|
2002-06-21 |
2005-07-13 |
Merck & Co. Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
CA2488484A1
(en)
|
2002-06-27 |
2004-01-08 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
JP2005533817A
(ja)
|
2002-06-28 |
2005-11-10 |
イデニクス(ケイマン)リミテツド |
フラビウィルス科ウィルス感染治療用の修飾2′および3′−ヌクレオシドプロドラッグ
|
PL374792A1
(en)
|
2002-06-28 |
2005-10-31 |
Idenix (Cayman) Limited |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
BR0312278A
(pt)
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
US20060264389A1
(en)
*
|
2002-07-16 |
2006-11-23 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
WO2004009610A2
(en)
|
2002-07-24 |
2004-01-29 |
Ptc Therapeutics, Inc. |
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
|
WO2004009020A2
(en)
|
2002-07-24 |
2004-01-29 |
Merck & Co., Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
CA2492607A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza d-nucleosides and uses thereof
|
JP4173861B2
(ja)
*
|
2002-09-13 |
2008-10-29 |
イデニクス(ケイマン)リミテツド |
耐性HBV菌株の治療のためのβ−L−2’−デオキシヌクレオシド及び併用療法
|
EP1576138B1
(en)
*
|
2002-11-15 |
2017-02-01 |
Idenix Pharmaceuticals LLC. |
2'-methyl nucleosides in combination with interferon and flaviviridae mutation
|
AU2003296601A1
(en)
*
|
2002-12-10 |
2004-06-30 |
F. Hoffmann-La Roche Ag |
Antiviral nucleoside derivatives
|
AU2003300901A1
(en)
|
2002-12-12 |
2004-06-30 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
WO2004084453A2
(en)
|
2003-03-20 |
2004-09-30 |
Microbiologica Quimica E Farmaceutica Ltd. |
METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
|
BRPI0409680A
(pt)
|
2003-04-25 |
2006-04-18 |
Gilead Sciences Inc |
análogos de fosfonato anti-cáncer
|
DK1628685T3
(da)
|
2003-04-25 |
2011-03-21 |
Gilead Sciences Inc |
Antivirale phosphonatanaloge
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
JP2006524710A
(ja)
|
2003-04-25 |
2006-11-02 |
ギリアード サイエンシーズ, インコーポレイテッド |
キナーゼインヒビターホスホネート抱合体
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
US7470724B2
(en)
*
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7452901B2
(en)
*
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US7595390B2
(en)
|
2003-04-28 |
2009-09-29 |
Novartis Ag |
Industrially scalable nucleoside synthesis
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
ES2726998T3
(es)
|
2003-05-30 |
2019-10-11 |
Gilead Pharmasset Llc |
Análogos de nucleósidos fluorados modificados
|
WO2005007810A2
(en)
|
2003-06-16 |
2005-01-27 |
Grinstaff Mark W |
Functional synthetic molecules and macromolecules for gene delivery
|
DE10331239A1
(de)
|
2003-07-10 |
2005-02-03 |
Robert Bosch Gmbh |
Überwachungselektronik für einen Elektromotor und Verfahren zur Überwachung eines Elektromotors
|
GB0317009D0
(en)
*
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
BRPI0412849A
(pt)
|
2003-07-25 |
2006-09-26 |
Idenix Cayman Ltd |
compostos, composições e usos de análogos de nucleosìdeo de purina para o tratamento de flaviviridae, incluindo hepatite c
|
JP2007504152A
(ja)
|
2003-08-27 |
2007-03-01 |
ビオタ, インコーポレイテッド |
治療剤としての新規三環ヌクレオシドまたはヌクレオチド
|
US20050148534A1
(en)
*
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
WO2005072361A2
(en)
|
2004-01-28 |
2005-08-11 |
Merck & Co., Inc. |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
US20060040944A1
(en)
*
|
2004-06-23 |
2006-02-23 |
Gilles Gosselin |
5-Aza-7-deazapurine derivatives for treating Flaviviridae
|
WO2006012440A2
(en)
*
|
2004-07-21 |
2006-02-02 |
Pharmasset, Inc. |
Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
WO2006029081A2
(en)
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
PT3109244T
(pt)
|
2004-09-14 |
2019-06-04 |
Gilead Pharmasset Llc |
¿preparação de ribofuranosil pirimidinas e purinas 2¿-fluoro-2¿-alquil substituídas ou outras opcionalmente substituídas e os seus derivados
|
BRPI0515896A
(pt)
|
2004-09-24 |
2008-08-12 |
Idenix Cayman Ltd E Ct Nat De |
composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus
|
CA2584367A1
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
|
GB0427123D0
(en)
|
2004-12-11 |
2005-01-12 |
Apv Systems Ltd |
Food item coating apparatus and method
|
CA2666098C
(en)
*
|
2006-10-10 |
2012-09-25 |
Steven D. Axt |
Preparation of nucleosides ribofuranosyl pyrimidines
|